Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

James Haddow

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Phenomena

False Positive Reactions

Geographic Areas

Maine

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Marcos Josep; Craig Wendy Y; Palomaki Glenn E; Kloza Edward M; Haddow James E; Roberson Marie; Bradley Linda A; Shackleton Cedric H L
Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies.
Haddow James E; McClain Monica R; Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
McClain Monica R; Lambert-Messerlian Geralyn; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of James Haddow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Marcos Josep; Craig Wendy Y; Palomaki Glenn E; Kloza Edward M; Haddow James E; Roberson Marie; Bradley Linda A; Shackleton Cedric H L
Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies.
Prenatal diagnosis 2009;29(8):771-80.
2008: Haddow James E; McClain Monica R; Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
The Journal of clinical endocrinology and metabolism 2008;93(9):3341-7.
2008: McClain Monica R; Lambert-Messerlian Geralyn; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.
American journal of obstetrics and gynecology 2008;199(2):129.e1-6.
2008: Lambert-Messerlian Geralyn; McClain Monica; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
American journal of obstetrics and gynecology 2008;199(1):62.e1-6.
2008: Palomaki Glenn E; Neveux Louis M; Donnenfeld Alan; Lee Jo Ellen S; McDowell Geraldine; Canick Jacob A; Summers Anne; Lambert-Messerlian Geralyn; Kellner Leonard H; Zebelman Arthur; Haddow James E
Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):131-8.
2008: McClain Monica R; Palomaki Glenn E; Piper Margaret; Haddow James E
A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):89-98.
2008: McClain Monica R; Palomaki Glenn E; Hampel Heather; Westman Judith A; Haddow James E
Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women.
Familial cancer 2008;7(4):341-5.
2007: Hollowell Joseph G; Haddow James E
The prevalence of iodine deficiency in women of reproductive age in the United States of America.
Public health nutrition 2007;10(12A):1532-9; discussion 1540-1.
2007: Shackleton Cedric H L; Marcos Josep; Palomaki Glenn E; Craig Wendy Y; Kelley Richard I; Kratz Lisa E; Haddow James E
Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS).
American journal of medical genetics. Part A 2007;143A(18):2129-36.
2007: Palomaki Glenn E; Neveux Louis M; Haddow James E; Wyatt Philip
Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
Prenatal diagnosis 2007;27(9):808-13.
2007: Palomaki Glenn E; Neveux Louis M; Knight George J; Haddow James E; Lee JoEllen
Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh sera.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(7):458-63.
2007: Craig Wendy Y; Haddow James E; Palomaki Glenn E; Roberson Marie
Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
Prenatal diagnosis 2007;27(5):409-14.
2007: Bradley Linda A; Kloza Edward M; Haddow Paula K; Beauregard Laurent J; Johnson Judith L; Haddow James E
A genetic history questionnaire-based system in primary prenatal care to screen for selected fetal disorders.
Genetic testing 2007;11(3):291-5.
2006: Craig Wendy Y; Haddow James E; Palomaki Glenn E; Kelley Richard I; Kratz Lisa E; Shackleton Cedric H L; Marcos Josep; Stephen Tint G; MacRae Andrew R; Nowaczyk Malgorzata J; Kloza Edward M; Irons Mira B; Roberson Marie
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome.
Prenatal diagnosis 2006;26(9):842-9.
2006: Palomaki Glenn E; Wright David E; Summers Anne M; Neveux Louis M; Meier Christian; O'donnell Andrea; Huang Tianhua; Knight George J; Haddow James E
Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Prenatal diagnosis 2006;26(8):730-9.
2006: Palomaki Glenn E; McClain Monica R; Steinort Klaus; Sifri Randa; LoPresti Leigh; Haddow James E
Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(3):161-8.
2006: Haddow James E; McClain Monica R; Palomaki Glenn E; Kloza Edward M; Williams Josephine
Screening for thyroid disorders during pregnancy: results of a survey in Maine.
American journal of obstetrics and gynecology 2006;194(2):471-4.
2006: Palomaki Glenn E; Steinort Klaus; Knight George J; Haddow James E
Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Obstetrics and gynecology 2006;107(2 Pt 1):367-75.
2005: Knight George J; Palomaki Glenn E; Neveux Louis M; Smith Dwight E; Kloza Edward M; Pulkkinen Andrea J; Williams Josephine; Haddow James E
Integrated serum screening for Down syndrome in primary obstetric practice.
Prenatal diagnosis 2005;25(12):1162-7.
2005: Palomaki Glenn E; Kloza Edward M; Haddow James E; Williams Josephine; Knight George J
Patient and health professional acceptance of integrated serum screening for Down syndrome.
Seminars in perinatology 2005;29(4):247-51.
2005: Palomaki Glenn E; Knight George J; Neveux Louis M; Pandian Raj; Haddow James E
Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening.
Clinical chemistry 2005;51(8):1499-504.
2005: McClain Monica R; Nathanson Katherine L; Palomaki Glenn E; Haddow James E
An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):34-9.
2005: McClain Monica R; Palomaki Glenn E; Nathanson Katherine L; Haddow James E
Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):28-33.
2004: Palomaki Glenn E; Neveux Louis M; Knight George J; Haddow James E; Pandian Raj
Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
Clinical chemistry 2004;50(10):1804-8.
2004: Palomaki Glenn E; FitzSimmons Stacey C; Haddow James E
Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(5):405-14.
2004: Haddow J E; Knight G J; Palomaki G E; McClain M R; Pulkkinen A J
The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.
Journal of medical screening 2004;11(4):170-4.
2003: Palomaki Glenn E; Haddow James E; Bradley Linda A; Richards C Sue; Stenzel Timothy T; Grody Wayne W
Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(6):440-3.
2003: Richards Carolyn S; Haddow James E
Prenatal screening for cystic fibrosis.
Clinics in laboratory medicine 2003;23(2):503-30, x-xi.
2003: Palomaki Glenn E; Neveux Louis M; Knight George J; Haddow James E
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Prenatal diagnosis 2003;23(3):243-7.
2003: Palomaki Glenn E; Bradley Linda A; Richards C Sue; Haddow James E
Analytic validity of cystic fibrosis testing: a preliminary estimate.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(1):15-20.
2002: Wald Nicholas J; Law Malcolm; Haddow James E; Craig Wendy Y
Apolipoprotiens and prediction of fatal myocardial infarction.
Lancet 2002;359(9320):1864.
2002: Palomaki Glenn E; Haddow James E; Bradley Linda A; FitzSimmons Stacey C
Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians.
Genetics in medicine : official journal of the American College of Medical Genetics 2002;4(2):90-4.
2002: Palomaki G E; Bradley L A; Knight G J; Craig W Y; Haddow J E
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome.
Journal of medical screening 2002;9(1):43-4.
2001: Allan W C; Timothy K; Vincent G M; Palomaki G E; Neveux L M; Haddow J E
Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting.
Journal of medical screening 2001;8(4):178-82.
2001: Allan W C; Timothy K; Vincent G M; Palomaki G E; Neveux L M; Haddow J E
Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population.
Journal of medical screening 2001;8(4):173-7.
2001: Knight G J; Palomaki G E; Neveux L M; Haddow J E; Lambert-Messerlian G M
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
Journal of medical screening 2001;8(1):2-7.
2001: Klein R Z; Sargent J D; Larsen P R; Waisbren S E; Haddow J E; Mitchell M L
Relation of severity of maternal hypothyroidism to cognitive development of offspring.
Journal of medical screening 2001;8(1):18-20.
2000: Mitchell M L; Hermos R J; Larson C A; Palomaki G E; Haddow J E
Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
Diabetes care 2000;23(11):1705-6.
2000: Allan W C; Haddow J E; Palomaki G E; Williams J R; Mitchell M L; Hermos R J; Faix J D; Klein R Z
Maternal thyroid deficiency and pregnancy complications: implications for population screening.
Journal of medical screening 2000;7(3):127-30.
1999: Haddow J E; Palomaki G E; Allan W C; Williams J R; Knight G J; Gagnon J; O'Heir C E; Mitchell M L; Hermos R J; Waisbren S E; Faix J D; Klein R Z
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.
The New England journal of medicine 1999;341(8):549-55.
1999: Bradley L A; Palomaki G E; Knight G J; Haddow J E; Opitz J M; Irons M; Kelley R I; Tint G S
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses.
American journal of medical genetics 1999;82(4):355-8.
1999: Haddow J E; Bradley L A; Palomaki G E; Doherty R A
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.
Journal of medical screening 1999;6(2):60-6.
1998: Watt H C; Law M R; Wald N J; Craig W Y; Ledue T B; Haddow J E
Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm.
International journal of epidemiology 1998;27(6):949-52.
1998: Craig W Y; Neveux L M; Palomaki G E; Cleveland M M; Haddow J E
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.
Clinical chemistry 1998;44(11):2301-6.
1998: Haddow J E
Antenatal screening for Down's syndrome: where are we and where next?
Lancet 1998;352(9125):336-7.
1998: Haddow J E; Palomaki G E; Knight G J; Williams J; Miller W A; Johnson A
Screening of maternal serum for fetal Down's syndrome in the first trimester.
The New England journal of medicine 1998;338(14):955-61.
1998: Wald N J; Watt H C; Haddow J E; Knight G J
Screening for Down syndrome at 14 weeks of pregnancy.
Prenatal diagnosis 1998;18(3):291-3.
1998: Knight G J; Palomaki G E; Neveux L M; Fodor K K; Haddow J E
hCG and the free beta-subunit as screening tests for Down syndrome.
Prenatal diagnosis 1998;18(3):235-45.
1998: Haddow J E; Palomaki G E; Knight G J; Foster D L; Neveux L M
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Journal of medical screening 1998;5(3):115-9.
1998: Bradley L A; Johnson D D; Palomaki G E; Haddow J E; Robertson N H; Ferrie R M
Hereditary haemochromatosis mutation frequencies in the general population.
Journal of medical screening 1998;5(1):34-6.
1997: Palomaki G E; Knight G J; McCarthy J E; Haddow J E; donhowe J M
Maternal serum screening for Down syndrome in the United States: a 1995 survey.
American journal of obstetrics and gynecology 1997;176(5):1046-51.
1997: Bradley L A; Canick J A; Palomaki G E; Haddow J E
Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency.
American journal of obstetrics and gynecology 1997;176(3):531-5.
1997: Doherty R A; Bradley L A; Haddow J E
Prenatal screening for cystic fibrosis: an updated perspective.
American journal of obstetrics and gynecology 1997;176(2):268-70.
1996: Neveux L M; Palomaki G E; Larrivee D A; Knight G J; Haddow J E
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Prenatal diagnosis 1996;16(12):1115-9.
1996: Haddow J E; Palomaki G E; Knight G J; Williams J; Chilmonczyk B A
Intervening to reduce environmental tobacco smoke exposure in infants.
Pediatrics 1996;98(3 Pt 1):513.
1996: Doherty R A; Palomaki G E; Kloza E M; Erickson J L; Haddow J E
Couple-based prenatal screening for cystic fibrosis in primary care settings.
Prenatal diagnosis 1996;16(5):397-404.
1996: Neveux L M; Palomaki G E; Knight G J; Haddow J E
Multiple marker screening for Down syndrome in twin pregnancies.
Prenatal diagnosis 1996;16(1):29-34.
1996: Bradley L A; Haddow J E; Palomaki G E
Population screening for haemochromatosis: a unifying analysis of published intervention trials.
Journal of medical screening 1996;3(4):178-84.
1996: Bradley L A; Haddow J E; Palomaki G E
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
Journal of medical screening 1996;3(4):171-7.
1996: Palomaki G E; Neveux L M; Haddow J E
Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?
Journal of medical screening 1996;3(1):12-7.
1995: Wald N J; Kennard A; Watt H; Haddow J E; Palomaki G E; Knight G; Canick J A
Decision analysis and screening for Down's syndrome. Testing should be in all women.
BMJ (Clinical research ed.) 1995;311(7016):1372-3.
1995: Palomaki G E; Haddow J E; Knight G J; Wald N J; Kennard A; Canick J A; Saller D N; Blitzer M G; Dickerman L H; Fisher R
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Prenatal diagnosis 1995;15(8):713-23.
1995: Haddow J E; Palomaki G E; Knight G J
Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening.
Journal of medical screening 1995;2(1):28-30.
1994: Palomaki G E; Bradley L A; Haddow J E
A new approach to analysing fluorescence in situ hybridisation data for rapid detection of aneuploidy in amniocytes.
Journal of medical screening 1994;1(2):96-7.
1994: Haddow J E; Knight G J; Palomaki G E; Neveux L M; Chilmonczyk B A
Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations.
Clinical chemistry 1994;40(4):562-4.
1994: Rose N C; Palomaki G E; Haddow J E; Goodman D B; Mennuti M T
Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older.
American journal of obstetrics and gynecology 1994;170(4):1073-8; discussion 1078-80.
1994: Haddow J E; Palomaki G E; Knight G J; Cunningham G C; Lustig L S; Boyd P A
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
The New England journal of medicine 1994;330(16):1114-8.
1994: Haddow J E; Ledue T B
Preventing manifestations of hereditary haemochromatosis through population based screening.
Journal of medical screening 1994;1(1):16-21.
1994: Doherty R A; Palomaki G E; Kloza E M; Erickson J L; Dostal D A; Haddow J E
Prenatal screening for cystic fibrosis.
Lancet 1994;343(8890):172.
1994: Palomaki G E; Knight G J; Haddow J E
Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
Prenatal diagnosis 1994;14(1):65-8.
1993: Palomaki G E; Knight G J; McCarthy J; Haddow J E; Eckfeldt J H
Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey.
American journal of obstetrics and gynecology 1993;169(6):1558-62.
1993: Chilmonczyk B A; Salmun L M; Megathlin K N; Neveux L M; Palomaki G E; Knight G J; Pulkkinen A J; Haddow J E
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children.
The New England journal of medicine 1993;328(23):1665-9.
1993: Palomaki G E; Knight G J; Haddow J E; Canick J A; Wald N J; Kennard A
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):675-8.
1993: Haddow J E; Palomaki G E; Holman M S
Young maternal age and smoking during pregnancy as risk factors for gastroschisis.
Teratology 1993;47(3):225-8.
1993: Donnenfeld A E; Pulkkinen A; Palomaki G E; Knight G J; Haddow J E
Simultaneous fetal and maternal cotinine levels in pregnant women smokers.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):781-2.
1992: Palomaki G E; Knight G J; Haddow J E; Canick J A; Saller D N; Panizza D S
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Prenatal diagnosis 1992;12(11):925-30.
1992: Haddow J E; Palomaki G E; Knight G J; Williams J; Pulkkinen A; Canick J A; Saller D N; Bowers G B
Prenatal screening for Down's syndrome with use of maternal serum markers.
The New England journal of medicine 1992;327(9):588-93.
1992: Chilmonczyk B A; Palomaki G E; Knight G J; Williams J; Haddow J E
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy.
American journal of diseases of children (1960) 1992;146(3):357-60.
1992: Haddow J E; Holman M S; Palomaki G E
Can gestational dates routinely derived from very early ultrasound be used to interpret maternal serum alpha-fetoprotein measurements?
Prenatal diagnosis 1992;12(1):65-8.
1991: Rose N C; Haddow J E; Palomaki G E; Knight G J
Self-rated physical activity level during the second trimester and pregnancy outcome.
Obstetrics and gynecology 1991;78(6):1078-80.
1991: Haddow J E; Rote N S; Dostal-Johnson D; Palomaki G E; Pulkkinen A J; Knight G J
Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester.
American journal of obstetrics and gynecology 1991;165(5 Pt 1):1308-12.
1991: Haddow J E; Knight G J; Kloza E M; Palomaki G E; Wald N J
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery.
British journal of obstetrics and gynaecology 1991;98(9):859-65.
1991: Klein R Z; Haddow J E; Faix J D; Brown R S; Hermos R J; Pulkkinen A; Mitchell M L
Prevalence of thyroid deficiency in pregnant women.
Clinical endocrinology 1991;35(1):41-6.
1990: Haddow J E
Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
Seminars in perinatology 1990;14(6):488-503.
1990: Chilmonczyk B A; Knight G J; Palomaki G E; Pulkkinen A J; Williams J; Haddow J E
Environmental tobacco smoke exposure during infancy.
American journal of public health 1990;80(10):1205-8.
1990: Johnson A M; Palomaki G E; Haddow J E
The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study.
American journal of obstetrics and gynecology 1990;163(1 Pt 1):9-11.
1990: Craig W Y; Palomaki G E; Johnson A M; Haddow J E
Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis.
Pediatrics 1990;85(2):155-8.
1990: Johnson A M; Palomaki G E; Haddow J E
Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study.
American journal of obstetrics and gynecology 1990;162(2):328-31.
1990: Palomaki G E; Knight G J; Holman M S; Haddow J E
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey.
American journal of obstetrics and gynecology 1990;162(2):317-21.
1989: Goldfine C; Haddow J E; Knight G J; Palomaki G E
Amniotic fluid alpha-fetoprotein and acetylcholinesterase measurements in pregnancies associated with gastroschisis.
Prenatal diagnosis 1989;9(10):697-700.
1989: Knight G J; Palomaki G E; Lea D H; Haddow J E
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay.
Clinical chemistry 1989;35(6):1036-9.
1989: Goldfine C; Knight G J; Haddow J E; Palomaki G E
Amniotic fluid acetylcholinesterase measurements: comparing immunochemical and polyacrylamide gel techniques.
Prenatal diagnosis 1989;9(3):167-72.
1989: Craig W Y; Palomaki G E; Haddow J E
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.
BMJ (Clinical research ed.) 1989;298(6676):784-8.
1988: Haddow J E; Knight G J; Palomaki G E; McCarthy J E
Second-trimester serum cotinine levels in nonsmokers in relation to birth weight.
American journal of obstetrics and gynecology 1988;159(2):481-4.
1988: Knight G J; Palomaki G E; Haddow J E
Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome.
Clinical obstetrics and gynecology 1988;31(2):306-27.
1988: Palomaki G E; Hill L E; Knight G J; Haddow J E; Carpenter M
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Obstetrics and gynecology 1988;71(6 Pt 1):906-9.
1987: Haddow J E; Knight G J; Palomaki G E; Kloza E M; Wald N J
Cigarette consumption and serum cotinine in relation to birthweight.
British journal of obstetrics and gynaecology 1987;94(7):678-81.
1987: Haddow J E; Hill L E; Palomaki G E; Knight G J
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
Prenatal diagnosis 1987;7(6):401-6.
1986: Haddow J E; Knight G J; Kloza E M; Palomaki G E
Alpha-fetoprotein, vaginal bleeding and pregnancy risk.
British journal of obstetrics and gynaecology 1986;93(6):589-93.
1985: Palomaki G E; Knight G J; Kloza E M; Haddow J E
Maternal weight adjustment and low serum alpha-fetoprotein values.
Lancet 1985;1(8426):468.
1985: Knight G J; Wylie P; Holman M S; Haddow J E
Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies.
Clinical chemistry 1985;31(1):118-21.
1984: Haddow J E; Palomaki G; Kloza E M; Knight G J
Does smoking influence serum alpha-fetoprotein levels in mid-trimester pregnancies?
British journal of obstetrics and gynaecology 1984;91(12):1188-91.
1984: Haddow J E; Knight G J; Pulkkinen A J; Smith D E
The relationship between serum beta 1-glycoprotein and alpha-fetoprotein levels in the second trimester and birth weight.
American journal of obstetrics and gynecology 1984;148(1):108-9.
1983: Haddow J E; Kloza E M; Smith D E; Knight G J
Data from an alpha-fetoprotein pilot screening program in Maine.
Obstetrics and gynecology 1983;62(5):556-60.
1982: Haddow J E; Knight G J; Kloza E M
Alpha-fetoprotein screening in pregnancy-a test whose time has come.
Arizona medicine 1982;39(7):436-9.
1982: Knight G J; Pulkkinen A J; Haddow J E
Levels of C-peptide in second-trimester amniotic fluid.
American journal of obstetrics and gynecology 1982;142(8):1062-3.
1981: Knight G J; Kloza E M; Smith D E; Haddow J E
Efficiency of human placental lactogen and alpha-fetoprotein measurement in twin pregnancy detection.
American journal of obstetrics and gynecology 1981;141(5):585-6.
1981: Haddow J E; Kloza E M; Knight G J; Smith D E
Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester.
Clinical chemistry 1981;27(1):133-4.
1980: Holman M S; Knight G J; Haddow J E
Acetylthiocholine iodide for detecting acetylcholinesterase activity in amniotic fluid.
Lancet 1980;2(8195 pt 1):651.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

James Haddow

Research Profile (preview)

Physiology

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Phenomena

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of James Haddow (preview)

All Publications